Skip to content
The Policy VaultThe Policy Vault

Epclusa (sofosbuvir/velpatasvir) — Highmark

hepatitis C virus (HCV) infection

Initial criteria

  • Member is 18 years of age or older
  • Diagnosis of chronic HCV (ICD-10: B18.2) OR for Mavyret, diagnosis of acute (ICD-10: B17) or chronic HCV (ICD-10: B18.2)
  • Member has not received prior HCV treatment
  • Prescriber provides all of the following information: member’s cirrhosis status